Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats
Authors:
- 31 March 2005
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 192 (1) , 184-193
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's diseaseNeurobiology of Disease, 2003
- The Effects of Different Repeated Doses of Entacapone on the Pharmacokinetics of L-Dopa and on the Clinical Response to L-Dopa in Parkinson's DiseaseClinical Neuropharmacology, 2001
- Subthalamotomy in parkinsonian monkeys Behavioural and biochemical analysisBrain, 1996
- Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primatesBrain Research, 1996
- Dyskinesia and wearing‐off following dopamine D1 agonist treatment in drug‐naive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned primatesMovement Disorders, 1996
- NMDA receptor blockade reverses motor response alterations induced by levodopaNeuroReport, 1994
- Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeysExperimental Neurology, 1992
- Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophreniaNeuroscience, 1991
- Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonistsEuropean Journal of Pharmacology, 1990
- Chronic treatment withl-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone bindingBrain Research, 1986